Business
Perimeter Medical Imaging AI Provides Corporate Update on Grant Funding Opportunities and Announces Conference Call/Webcast to Discuss Fourth Quarter and Year-End 2023 Financial Results
Perimeter Medical Imaging AI Provides Corporate Update on Grant Funding Opportunities and Announc...
About this update from Perimeter Medical Imaging Ai Inc
[{"type":"text","content":"\n \n \n \n Perimeter Medical Imaging AI Provides Corporate Update on Grant Funding Opportunities and Announces Conference Call/Webcast to Discuss Fourth Quarter and Year-End 2023 Financial Results\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prnml40{\nMARGIN-LEFT:3.33em !IMPORTANT\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n \n DALLAS\n \n and\n \n TORONTO\n \n \n ,\n \n \n March 20, 2024\n \n \n /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) (\"Perimeter\" or the \"Company\") – a commercial-stage medical technology company – announced upcoming events and provided a corporate update on grant funding opportunities to support its next-generation AI technology development.\n \n \n \n Adrian Mendes\n \n , Perimeter's Chief Executive Officer, stated, \"As we continue to ramp the number of surgeons using our technology, we are excited to showcase our flagship Perimeter S-Series OCT technology at an international conference hosted by the Society of Surgical Oncology. This is an important opportunity to connect with key customers and educate the broader surgical community about the benefits of using Perimeter's innovative technology to assist with visualizing margins real-time in their ORs.\"\n \n \n \n Society of Surgical Oncology (SSO) International Conference on Surgical Cancer Care -\n \n #SSO2024\n \n \n \n \n \n Dates:\n \n March 20-23, 2024\n \n \n \n Location:\n \n Georgia World Congress Center,\n \n Atlanta, GA\n \n \n \n Mr. Mendes continued, \"Turning to the product development side of the business, although we were shortlisted to the final stages, we did not receive funding from this tranche of the federal PSI grant program sponsored by the Advanced Research Projects Agency for Health (ARPA-H). Although disappointing, it's important to note that these funds were proposed for future tissue type investigations and related product development. All of our current clinical and product development plans remain on track and within our current financial modeling, including a planned interim read-out from ...